3-iodobenzylguanidine has been researched along with Angiomyolipoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayashi, M; Iha, T; Kouki, T; Ogawa, Y; Ohshiro, Y; Takara, M; Takasu, N | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and Angiomyolipoma
Article | Year |
---|---|
False-positive 123I-metaiodobenzylguanidine (MIBG) scan in a patient with angiomyolipoma; positive MIBG scan does not necessarily indicate the presence of pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Angiomyolipoma; Diagnosis, Differential; False Positive Reactions; Female; Humans; Magnetic Resonance Angiography; Pheochromocytoma; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2007 |